Haematogenous dissemination of Leishmania (Viannia) braziliensis in human American tegumentary leishmaniasis.

[1]  E. Cupolillo,et al.  Leishmania (Viannia): genetic analysis of cutaneous and mucosal strains isolated from the same patient. , 2004, Experimental parasitology.

[2]  P. Desjeux.  Leishmaniasis: current situation and new perspectives. , 2004, Comparative immunology, microbiology and infectious diseases.

[3]  E. Rodrigues,et al.  Persistence of leishmania parasites in scars after clinical cure of American cutaneous leishmaniasis: is there a sterile cure? , 2004, The Journal of infectious diseases.

[4]  E. Cupolillo,et al.  Epidemiological and clinical features of Leishmania (Viannia) braziliensis American cutaneous and mucocutaneous leishmaniasis in the State of Espírito Santo, Brazil. , 2003, Memorias do Instituto Oswaldo Cruz.

[5]  C. Pirmez,et al.  Parasitological and immunological follow-up of American tegumentary leishmaniasis patients. , 2002, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[6]  O. Fernandes,et al.  Mucosal leishmaniasis ("espundia") responsive to low dose of N-methyl glucamine (Glucantime) in Rio de Janeiro, Brazil. , 2000, Revista do Instituto de Medicina Tropical de Sao Paulo.

[7]  O. Fernandes,et al.  American tegumentary leishmaniasis (ATL) in Rio de Janeiro State, Brazil: main clinical and epidemiologic characteristics , 2000, International journal of dermatology.

[8]  G. Wortmann,et al.  Cutaneous leishmaniasis following local trauma: a clinical pearl. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  S. Barreto,et al.  American cutaneous leishmaniasis: use of a skin test as a predictor of relapse after treatment. , 2000, Bulletin of the World Health Organization.

[10]  W. Degrave,et al.  Use of PCR in Diagnosis of Human American Tegumentary Leishmaniasis in Rio de Janeiro, Brazil , 1999, Journal of Clinical Microbiology.

[11]  W. Degrave,et al.  Detection of Leishmania DNA by polymerase chain reaction in scars of treated human patients. , 1998, The Journal of infectious diseases.

[12]  Arlindo L. Oliveira,et al.  Cutaneous scars in American tegumentary leishmaniasis patients: a site of Leishmania (Viannia) braziliensis persistence and viability eleven years after antimonial therapy and clinical cure. , 1998, The American journal of tropical medicine and hygiene.

[13]  O. Fernandes,et al.  American cutaneous leishmaniasis associated with HIV infection: report of four cases , 1998, Journal of the European Academy of Dermatology and Venereology : JEADV.

[14]  R. López-Vélez,et al.  Leishmania and human immunodeficiency virus coinfection: the first 10 years , 1997, Clinical microbiology reviews.

[15]  J. Blackwell,et al.  Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis , 1995, The Journal of experimental medicine.

[16]  J. David,et al.  Bubonic leishmaniasis: a common manifestation of Leishmania (Viannia) braziliensis infection in Ceara, Brazil. , 1995, The American journal of tropical medicine and hygiene.

[17]  N. Añez,et al.  Presence of Leishmania braziliensis in blood samples from cured patients or at different stages of immunotherapy. , 1994, Clinical and diagnostic laboratory immunology.

[18]  S. Coutinho,et al.  An experimental model of the production of metastases in murine cutaneous leishmaniasis. , 1994, The Journal of parasitology.

[19]  T. Aebischer.  Recurrent cutaneous leishmaniasis: a role for persistent parasites? , 1994, Parasitology today.

[20]  E. Handman,et al.  Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host , 1993, Infection and immunity.

[21]  B. Radovancević,et al.  Leishmaniasis in a heart transplant patient. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[22]  Alba,et al.  Haemoculture of Leishmania (Viannia) braziliensis from two cases of mucosal leishmaniasis: re-examination of haematogenous dissemination. , 1992, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[23]  O. Rossell,et al.  Is leishmaniasis ever cured? , 1992, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[24]  J. Granados,et al.  Immunogenetics of human American cutaneous leishmaniasis. Study of HLA haplotypes in 24 families from Venezuela. , 1991, Human immunology.

[25]  C. Pirmez,et al.  Immunologic responsiveness in American cutaneous leishmaniasis lesions. , 1990, Journal of immunology.

[26]  A. Gonçalves,et al.  Recurrent lesions in human Leishmania braziliensis infection—reactivation or reinfection? , 1990, The Lancet.

[27]  R. Badaró,et al.  Long-term follow-up of patients with Leishmania (Viannia) braziliensis infection and treated with Glucantime. , 1990, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[28]  Adelson A. Souza,et al.  Sobre a sensibilidade da cultura de leucócitos circulantes na detecção de Leishmania no sangue periférico de pacientes com leishmaniose tegumentar , 1989 .

[29]  C. Pirmez,et al.  An outbreak of American cutaneous leishmaniasis (Leishmania braziliensis braziliensis) in a periurban area of Rio de Janeiro city, Brazil: clinical and epidemiological studies. , 1988, Memorias do Instituto Oswaldo Cruz.

[30]  C. Pirmez,et al.  Human american cutaneous leishmaniasis (Leishmania b. braziliensis) in Brazil: lymphoproliferative responses and influence of therapy. , 1986, Clinical and experimental immunology.

[31]  P. Marsden.  Mucosal leishmaniasis ("espundia" Escomel, 1911). , 1986, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[32]  P. Marsden,et al.  Failure to detect circulating Leishmania in mucocutaneous leishmaniasis due to Leishmania braziliensis braziliensis. , 1986, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[33]  N. Saravia,et al.  RECURRENCES OF TEGUMENTARY LEISHMANIASIS , 1985, The Lancet.

[34]  J. M. L. Costa,et al.  Leishmaniose mucocutânea humana em Três Braços, Bahia - Brasil: uma área de transmissão de Leishmania braziliensis braziliensis. III. Comprometimento mucoso e evolução inicial , 1984 .

[35]  W. Johnson,et al.  Human mucocutaneous leishmaniasis in Três Braços, Bahia - Brazil: an area of Leishmania braziliensis braziliensis transmission. II. Cutaneous disease. Presentation and evolution , 1984 .

[36]  S. Reed,et al.  Human mucocutaneous leishmaniasis in Três Braços, Bahia - Brazil: an area of Leishmania braziliensis braziliensis transmission. I. Laboratory diagnosis , 1984 .

[37]  D. Walker,et al.  American mucocutaneous leishmaniasis. Culture of a Leishmania species from peripheral blood leukocytes. , 1981, American journal of clinical pathology.

[38]  T. Self,et al.  DRUG ENHANCEMENT OF WARFARIN ACTIVITY , 1975, The Lancet.